The Claim
In rat kidney homogenates under in vitro conditions, exendin-4 is primarily degraded at the peptide bonds between amino acids Met14-Glu15 and Glu15-Glu16, resulting in the formation of exendin-4(15–39) and exendin-4(16–39) as the main initial metabolites.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When scientists studied a lab-made version of a hormone in rat kidney mixtures, they found it breaks apart at two specific spots, creating two smaller pieces as the first step in its breakdown.
See the scientific wording
In rat kidney homogenates, the primary cleavage sites for exendin-4 degradation are located between amino acids 14–15 (Met14-Glu15) and 15–16 (Glu15-Glu16), leading to the formation of exendin-4(15–39) and exendin-4(16–39) as the predominant initial metabolites under in vitro conditions.
What the research says
1 studyStudy: In Vitro Metabolic Stability of Exendin-4: Pharmacokinetics and Identification of Cleavage Products
The study looked at how a drug called exendin-4 breaks down in rat kidney tissue, and found it splits at the exact spots the claim says it does.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.